X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
64
PharmaCompass offers a list of Adenosine Triphosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Adenosine Triphosphate manufacturer or Adenosine Triphosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Adenosine Triphosphate manufacturer or Adenosine Triphosphate supplier.
PharmaCompass also assists you with knowing the Adenosine Triphosphate API Price utilized in the formulation of products. Adenosine Triphosphate API Price is not always fixed or binding as the Adenosine Triphosphate Price is obtained through a variety of data sources. The Adenosine Triphosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 065A467 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 065A467, including repackagers and relabelers. The FDA regulates 065A467 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 065A467 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 065A467 supplier is an individual or a company that provides 065A467 active pharmaceutical ingredient (API) or 065A467 finished formulations upon request. The 065A467 suppliers may include 065A467 API manufacturers, exporters, distributors and traders.
click here to find a list of 065A467 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 065A467 DMF (Drug Master File) is a document detailing the whole manufacturing process of 065A467 active pharmaceutical ingredient (API) in detail. Different forms of 065A467 DMFs exist exist since differing nations have different regulations, such as 065A467 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 065A467 DMF submitted to regulatory agencies in the US is known as a USDMF. 065A467 USDMF includes data on 065A467's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 065A467 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 065A467 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 065A467 Drug Master File in Japan (065A467 JDMF) empowers 065A467 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 065A467 JDMF during the approval evaluation for pharmaceutical products. At the time of 065A467 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 065A467 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 065A467 Drug Master File in Korea (065A467 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 065A467. The MFDS reviews the 065A467 KDMF as part of the drug registration process and uses the information provided in the 065A467 KDMF to evaluate the safety and efficacy of the drug.
After submitting a 065A467 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 065A467 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 065A467 suppliers with KDMF on PharmaCompass.
065A467 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 065A467 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 065A467 GMP manufacturer or 065A467 GMP API supplier for your needs.
A 065A467 CoA (Certificate of Analysis) is a formal document that attests to 065A467's compliance with 065A467 specifications and serves as a tool for batch-level quality control.
065A467 CoA mostly includes findings from lab analyses of a specific batch. For each 065A467 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
065A467 may be tested according to a variety of international standards, such as European Pharmacopoeia (065A467 EP), 065A467 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (065A467 USP).
Market Place
